Market Performance
Pennant /The (ticker PNTG) closed 1.06 % lower at USD 41.04 on Thursday 22 Oct 2026, with trading ending at 06:52 AM Central Europe. The stock’s 24‑hour trading volume totaled USD 8.5 million, and the current supply of shares is 35 million. The company’s market capitalization stands at USD 1.5 billion.
The price movement over the past month shows a 4.14 % increase relative to the previous month‑end value. The 200‑day simple moving average is USD 34.97. Within the last 52 weeks, the highest recorded price was USD 42.74 on 17 Sep 2026, while the lowest was USD 22.26 on 6 Nov 2025.
Peer Activity
| Company | Recent Change | Current Price (USD) | Market Capitalization (USD) | P/E Ratio |
|---|---|---|---|---|
| Stoke Therapeutics (STOK) | –3.49 % | 25.68 | 1.7 billion | – |
| S & T (STBA) | –0.77 % | 48.86 | 1.7 billion | 13.07 |
| Urogen Pharma (URGN) | +1.34 % | 35.48 | 1.7 billion | – |
| Sharplink (SBET) | +6.10 % | 8.35 | 1.7 billion | – |
| Pdf (PDFS) | +6.87 % | 44.01 | 1.7 billion | 164.71 |
Company Overview
The Pennant Group, Inc. is a healthcare holding company that operates in Idaho. Through its subsidiaries, it provides nursing, senior care, and ancillary services. Additional information about the company’s services is available on the website www.pennantgroup.com . The company’s shares are traded on the Nasdaq stock exchange.
